Covidence announces changes to subscriptions, but free access for Cochrane Reviews and Cochrane author teams continues
If you have signed into Covidence this week (which we hope many of you have done!), you may have noticed a notification informing users about the introduction of subscription charges for the use of Covidence. We are happy to confirm that all Cochrane Reviews will always be free in Covidence, thanks to Cochrane’s partnership as co-owners of the Covidence tool. In addition, all non-Cochrane reviews already begun in Covidence will remain free. The subscription charges being introduced will not affect your use of Covidence to produce your Cochrane Reviews.
Why are charges being introduced?
Covidence is a non-profit product, developed with the primary goal of improving the public good. In pursuit of this goal the Covidence team has raised funds from grants and through partnerships with other non-profits, particularly Cochrane. However, with the very rapid growth in users over the last six months comes higher costs. In order to continue to support Covidence users and keep improving Covidence a sustainable, long-term income stream is needed.
How do I use Covidence for free for my Cochrane work?
Cochrane will always provide Covidence free of charge for Cochrane Reviews. To ensure that Covidence recognises your reviews as Cochrane reviews, it will be important to make sure that you use your Archie login to access your Covidence account. You should also ensure that when you start a new review project, you select the review title from the available titles Covidence can access in Archie.